Multicenter retrospective analysis by the Polish Adult Leukemia Group on tuberculosis occurrence and outcomes after hematopoietic cell transplantation

Tuberculosis (TB) is an infectious complication of hematopoietic cell transplantation (HCT). There is a paucity of data on TB after HCT. Here we present the data from a low/low-intermediate TB-burden country. This was a Retrospective analysis of adult patients who developed TB after HCT. Seventeen patients were identified, 9 (52.9%) females, the median age at TB 44 years. Five (29.4%) patients underwent auto-HCT, 12 (70.6%) allo-HCT, translating into the relative frequency of TB of 0.171% for allo-HCT, and 0.063% for auto-HCT. The median time from HCT to TB was 431 days (range, 5-973). All patients had pulmonary TB. Bacteriologically confirmed TB was diagnosed in 13 (76.5%) patients; drug susceptibility testing was performed in 3/13 (23.1%). The median duration of treatment was 6 months. Twelve out of 13 evaluable patients (92.3%) obtained treatment success. With a median follow-up of 48 months (95%CI 19-95) 1-year cumulative incidence of TB-associated death was 6.7% (95%CI 0.9-40.8%). To conclude TB is a very rare infectious complication of HCT. Most frequently TB develops late after HCT. The primary site involved is the lung with no extrapulmonary TB identified in the current analysis. TB can still result in the death of the affected patient.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-05-11
DOI
https://doi.org/10.1038/s41598-026-51064-2
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multicenter retrospective analysis by the Polish Adult Leukemia Group on tuberculosis occurrence and outcomes after hematopoietic cell transplantation

Jarosław Dybko, Joanna Kujawska, Barbara Nasiłowska‐Adamska, Anna Waszczuk‐Gajda et al.
Scientific Reports
Tuberculosis Research and Epidemiology
article

Multicenter retrospective analysis by the Polish Adult Leukemia Group on tuberculosis occurrence and outcomes after hematopoietic cell transplantation

Jarosław Dybko, Joanna Kujawska, Barbara Nasiłowska‐Adamska, Anna Waszczuk‐Gajda, Małgorzata Proboszcz, Agnieszka Piekarska, Justyna Rybka, Izabela Dereń-Wagemann, Mariola Sędzimirska, Łukasz Bołkuń, Magdalena Tormanowska, Joanna Romejko‐Jarosińska, Grzegorz Basak, Anna Kopińska, Sebastian Giebel, Przemysław Biecek, Paweł Szwedyk, Joanna Drozd-Sokołowska, Agnieszka Tomaszewska, Małgorzata Sobczyk-Kruszelnicka, Elżbieta Sienkiewicz, Lidia Gil
article en

Abstract

Tuberculosis (TB) is an infectious complication of hematopoietic cell transplantation (HCT). There is a paucity of data on TB after HCT. Here we present the data from a low/low-intermediate TB-burden country. This was a Retrospective analysis of adult patients who developed TB after HCT. Seventeen patients were identified, 9 (52.9%) females, the median age at TB 44 years. Five (29.4%) patients underwent auto-HCT, 12 (70.6%) allo-HCT, translating into the relative frequency of TB of 0.171% for allo-HCT, and 0.063% for auto-HCT. The median time from HCT to TB was 431 days (range, 5-973). All patients had pulmonary TB. Bacteriologically confirmed TB was diagnosed in 13 (76.5%) patients; drug susceptibility testing was performed in 3/13 (23.1%). The median duration of treatment was 6 months. Twelve out of 13 evaluable patients (92.3%) obtained treatment success. With a median follow-up of 48 months (95%CI 19-95) 1-year cumulative incidence of TB-associated death was 6.7% (95%CI 0.9-40.8%). To conclude TB is a very rare infectious complication of HCT. Most frequently TB develops late after HCT. The primary site involved is the lung with no extrapulmonary TB identified in the current analysis. TB can still result in the death of the affected patient.

Scientific Reports
Warsaw University of Technology (PL), Poznan University of Medical Sciences (PL), Medical University of Białystok (PL), Medical University of Silesia (PL), Medical University of Warsaw (PL), Wroclaw Medical University (PL), Instytut Hematologii i Transfuzjologi (PL), National Institute of Oncology (HU), German National Bone Marrow Donor Registry (DE), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Gdańsk Medical University (PL)
Good health and well-being
Openalex Percentile: Top 6%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.